Growth Metrics

Merck (MRK) Receivables - Other (2016 - 2023)

Merck (MRK) has disclosed Receivables - Other for 12 consecutive years, with $473.0 million as the latest value for Q1 2023.

  • Quarterly Receivables - Other fell 34.21% to $473.0 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $473.0 million through Mar 2023, down 34.21% year-over-year, with the annual reading at $511.0 million for FY2022, 46.99% down from the prior year.
  • Receivables - Other for Q1 2023 was $473.0 million at Merck, down from $511.0 million in the prior quarter.
  • The five-year high for Receivables - Other was $1.6 billion in Q2 2021, with the low at $473.0 million in Q1 2023.
  • Average Receivables - Other over 3 years is $860.4 million, with a median of $684.0 million recorded in 2022.
  • The sharpest move saw Receivables - Other crashed 59.5% in 2022, then crashed 34.21% in 2023.
  • Over 3 years, Receivables - Other stood at $964.0 million in 2021, then crashed by 46.99% to $511.0 million in 2022, then fell by 7.44% to $473.0 million in 2023.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $473.0 million, $511.0 million, and $567.0 million for Q1 2023, Q4 2022, and Q3 2022 respectively.